Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Scott

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Clinical and Translational Science|August 20, 2021
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approachJorge Duconge, Ednalise Santiago, Dagmar F Hernandez-Suarez, et al.
Thrombosis and Haemostasis|May 17, 2013
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivityUsman Baber, Jeffrey Bander, Rucha Karajgikar, et al.
Clinical Pharmacology and Therapeutics|July 1, 2020
PharmVar GeneFocus: CYP2C19Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, et al.
Journal of Personalized Medicine|June 2, 2021
Multi-Institutional Implementation of Clinical Decision Support for <i>APOL1, NAT2,</i> and <i>YEATS4</i> Genotyping in Antihypertensive ManagementThomas M Schneider, Michael T Eadon, Rhonda M Cooper-DeHoff, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 UpdateCraig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
The Journal of Molecular Diagnostics : JMD|May 29, 2026
Analytical validation of short-read genome sequencing for diagnostic panel and exome testingYao Yang, Nathan A Hammond, Pun Wai Tong, et al.
Clinical Pharmacology and Therapeutics|June 5, 2025
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesD Max Smith, Michael P Douglas, Christina L Aquilante, et al.
Journal of the American College of Cardiology|March 25, 2017
Apolipoprotein L1 Variants and Blood Pressure Traits in African AmericansGirish N Nadkarni, Geneviève Galarneau, Stephen B Ellis, et al.
Clinical Pharmacology and Therapeutics|April 9, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor AntidepressantsChad A Bousman, James M Stevenson, Laura B Ramsey, et al.
Clinical Pharmacology and Therapeutics|August 10, 2020
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor DosingJohn J Lima, Cameron D Thomas, Julia Barbarino, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Clinical and Translational Science|August 20, 2021
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approachJorge Duconge, Ednalise Santiago, Dagmar F Hernandez-Suarez, et al.
Thrombosis and Haemostasis|May 17, 2013
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivityUsman Baber, Jeffrey Bander, Rucha Karajgikar, et al.
Clinical Pharmacology and Therapeutics|July 1, 2020
PharmVar GeneFocus: CYP2C19Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, et al.
Journal of Personalized Medicine|June 2, 2021
Multi-Institutional Implementation of Clinical Decision Support for <i>APOL1, NAT2,</i> and <i>YEATS4</i> Genotyping in Antihypertensive ManagementThomas M Schneider, Michael T Eadon, Rhonda M Cooper-DeHoff, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 UpdateCraig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
The Journal of Molecular Diagnostics : JMD|May 29, 2026
Analytical validation of short-read genome sequencing for diagnostic panel and exome testingYao Yang, Nathan A Hammond, Pun Wai Tong, et al.
Clinical Pharmacology and Therapeutics|June 5, 2025
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesD Max Smith, Michael P Douglas, Christina L Aquilante, et al.
Journal of the American College of Cardiology|March 25, 2017
Apolipoprotein L1 Variants and Blood Pressure Traits in African AmericansGirish N Nadkarni, Geneviève Galarneau, Stephen B Ellis, et al.
Clinical Pharmacology and Therapeutics|April 9, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor AntidepressantsChad A Bousman, James M Stevenson, Laura B Ramsey, et al.
Clinical Pharmacology and Therapeutics|August 10, 2020
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor DosingJohn J Lima, Cameron D Thomas, Julia Barbarino, et al.
Pageof 15